| # | Drug | Count |
|---|---|---|
| 0 | AGALSIDASE BETA | 23 |
| 1 | FUROSEMIDE | 9 |
| 2 | CARBAMAZEPINE | 7 |
| 3 | CYCLOSPORINE | 4 |
| 4 | VALSARTAN | 4 |
| 5 | ACETAMINOPHEN | 3 |
| 6 | ATORVASTATIN CALCIUM | 3 |
| 7 | DIPHENHYDRAMINE HYDROCHLORIDE | 3 |
| 8 | GABAPENTIN | 3 |
| 9 | MYCOPHENOLATE MOFETIL | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AGALSIDASE BETA | 23 | 0.0025 |
| 1 | CLONIDINE TRANSDERMAL SYSTEM | 1 | 0.0005 |
| 2 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 2 | 0.0001 |
| 3 | EXTENDED PHENYTOIN SODIUM | 2 | 0.0001 |
| 4 | CARBAMAZEPINE | 7 | 0.0001 |
| 5 | IRON SUCROSE | 1 | 0.0001 |
| 6 | DASPONE | 1 | 0.0001 |
| 7 | DAPSONE GEL, 5% | 1 | 0.0001 |
| 8 | DAPSONE | 1 | 0.0001 |
| 9 | AMIODARONE HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 23 | 0.0024 |
| 1 | Sulfone [EPC] | 1 | 0.0001 |
| 2 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 3 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 4 | Central alpha-2 Adrenergic Agonist [EPC] | 2 | 0.0000 |
| 5 | Erythropoiesis-stimulating Agent [EPC] | 2 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 7 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 | 0.0000 |